

School of Pharmacy, University of Barcelona.
Av. Diagonal 643, 08028 Barcelona
Phone. (93) 403-4455, Fax: (93) 402-4520,
E-mail : CCiudad@ub.edu; vnoe@ub.edu
Updated: October-24-2011
OBJECTIVES
• To improve already existent cancer chemotherapy treatments to increase their effectivity.
• To study the regulation of genes involved in the resistance to chemotherapy
• To investigate new alternative therapies based on the new developments in Biochemistry and Molecular Biology.
• As a model we use the gene encoding for Dihydrofolate reductase (DHFR), enzyme that it is widely
used as the target for the chemotherapy that uses methotrexate.
RESEARCH INTERESTS
• To study the process that develops resistance to chemotherapy.
• To find modulators of chemotherapy resistance
• To study the transcriptional regulation of the dhfr gene
• To study the effect of transcription factors, oncogenes and tumor suppressors on the expression of the dhfr gene.
• To investigate in detail the regulation of the transcription factor Sp1 and Sp3
• To explore the postranscriptional regulation of the DHFR RNA.
• To investigate the role of introns on the expression of the dhfr gene into protein
• Cloning of genes responsible for the resistance that arises upon cancer chemotherapy.
• Probing the applicability of antisense oligonucleotides and siRNA in cancer therapy
• Usage of aptamers to deliver gene therapy molecules to target cells .
• To design immunoliposomes for introducing oligonucleotides into the cells.
• Identification of target genes involved in the activation of apoptosis and in the inhibition of angiogenesis: Survivin.
• To repair DNA mutations at the endogenous locus using Polypurine Hairpins.
• Genomic studies related to Methotrexate resistance: Arrays and MicroArrays
• Regulation of Methotrexate resistance by microRNAs
• Networking of differentially expressed genes in methotrexate resistant cells
• Usage of polypurine hairpins against gene expression: Studies in vitro and in vivo